ArticleExploratory research in clinical and social pharmacy2026
Transitions of care between pediatric onco-hematology and intensive care units: An exploratory study of healthcare professionals' perceptions and practices in medication management.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As in adult care, pediatric patients experience transitions in their care trajectory, such as transfers to intensive care units (ICUs) during episodes of clinical deterioration. In pediatric onco-hematology, the administration of Chimeric Antigen Receptor (CAR) T-cell therapy often necessitates several days of ICU admission for post-infusion monitoring. As a result, systematic collaboration between pediatric onco-hematology and intensive care teams is becoming standard for these advanced therapies. Objective: This study aimed to explore healthcare professionals' perceptions, experiences, and practices related to medication management during transitions of care between pediatric onco-hematology and ICU settings. Methods: Semi-structured interviews were conducted with healthcare professionals from both specialties. Transcripts were analyzed using a manual inductive approach. Results: Twenty-four healthcare professionals participated (14 ICU, 10 onco-hematology). Themes emerged: (1) the clinical complexity of onco-hematology patients, (2) technical and logistical barriers (e.g., software incompatibility, clinical transfers, medication transfer), (3) the specific involvement of parents in pediatric care. Emergency ICU admissions were identified as the highest-risk transfer for medication-related adverse events. Improvements included three essential areas: information diffusion especially improving written one and verbal nursing transmissions, implementing trainings and practices standardization by instance for intravenous medications. Clinical pharmacists can help in those improvement areas and so need to be implemented in pediatric ICU and work on those transitions to reduce medication errors. Conclusion: These findings underscore the need to optimize medication safety during care transitions. Strategic efforts such as interdisciplinary collaboration, standardized protocols, and pharmacist involvement can help reduce risks and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.